Ryan M. Gill, MD, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Ryan M. Gill, MD, PhD

Associate Professor of Clinical Pathology, UCSF

Phone: (415) 476-3212
Box 0102, UCSF
San Francisco, CA 94143

UCSF Profiles

Education

University of Kansas, Kansas City, KS, PhD, 2003, Pathology
University of Kansas, Kansas City, KS, MD, 2005, Medicine
University of California, San Francisco, Resident, 2006, Laboratory Medicine
University of California, San Francisco, Resident, 2008, Pathology
University of California, San Francisco, Chief Resident, 2009, Laboratory Medicine
University of California, San Francisco, Fellow, 2010, Hematopathology
University of California, San Francisco, Fellow, 2011, Gastrointestinal/Liver Pathology


Professional Experience

  • 2010-2011
    HS Clinical Instructor of Pathology, University of California, San Francisco
  • 2011-2014
    Assistant Professor of Clinical Pathology, University of California, San Francisco
  • 2011-2014
    Associate Residency Director, Department of Pathology, University of California, San Francisco
  • 2014-present
    Associate Professor of Clinical Pathology, University of California, San Francisco
  • 2014-present
    Associate Director of Surgical Pathology, University of California, San Francisco

Honors & Awards

  • 2003
    Merit Award, American Society for Investigative Pathology
  • 2006
    Resident Research Award, UCSF Department of Laboratory Medicine
  • 2009
    Diplomate, Anatomic and Clinical Pathology, American Board of Pathology
  • 2010
    Diplomate, Hematology, American Board of Pathology

Selected Publications

  1. Chen B, Wei W, Ma L, Yang B, Gill RM, Chua MS, Butte AJ, So S. Computational Discovery of Niclosamide Ethanolamine, A Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells in Vitro and in Mice by Inhibiting CDC37 Signaling. Gastroenterology. 2017 Mar 08.
    View on PubMed
  2. Tsai JH, Ferrell LD, Tan V, Yeh MM, Sarkar M, Gill RM. Aggressive non-alcoholic steatohepatitis following rapid weight loss and/or malnutrition. Mod Pathol. 2017 Mar 03.
    View on PubMed
  3. Geha R, Peters M, Gill RM, Dhaliwal G. Histology Rings True. N Engl J Med. 2017 03 02; 376(9):869-874.
    View on PubMed
  4. Bean GR, Joseph NM, Gill RM, Folpe AL, Horvai AE, Umetsu SE. Recurrent GNAQ mutations in anastomosing hemangiomas. Mod Pathol. 2017 Jan 13.
    View on PubMed
  5. Choi WT, Jen KY, Wang D, Tavakol M, Roberts JP, Gill RM. Donor Liver Small Droplet Macrovesicular Steatosis is Associated With Increased Risk for Recipient Allograft Rejection. Am J Surg Pathol. 2017 Jan 04.
    View on PubMed
  6. Giard JM, Decker KA, Lai JC, Gill RM, Logan AC, Fix OK. Acute Liver Failure Secondary to Hemophagocytic Lymphohistiocytosis during Pregnancy. ACG Case Rep J. 2016 Aug; 3(4):e162.
    View on PubMed
  7. Nelson JE, Handa P, Aouizerat B, Wilson L, Vemulakonda LA, Yeh MM, Kowdley KV. Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms. Aliment Pharmacol Ther. 2016 Oct 11.
    View on PubMed
  8. Schwimmer JB, Lavine JE, Wilson LA, Neuschwander-Tetri BA, Xanthakos SA, Kohli R, Barlow SE, Vos MB, Karpen SJ, Molleston JP, Whitington PF, Rosenthal P, Jain AK, Murray KF, Brunt EM, Kleiner DE, Van Natta ML, Clark JM, Tonascia J, Doo E. In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores. Gastroenterology. 2016 Aug 26.
    View on PubMed
  9. Ajmera V, Perito ER, Bass NM, Terrault NA, Yates KP, Gill R, Loomba R, Diehl AM, Aouizerat B. Novel Plasma Biomarkers Associated with Liver Disease Severity in Adults with Nonalcoholic Fatty Liver Disease. Hepatology. 2016 Aug 17.
    View on PubMed
  10. Yang JD, Abdelmalek MF, Guy CD, Gill RM, Lavine JE, Yates K, Klair J, Terrault NA, Clark JM, Unalp-Arida A, Diehl AM, Suzuki A. Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic Steatohepatitis. Clin Gastroenterol Hepatol. 2016 Aug 12.
    View on PubMed
  11. Hale G, Liu X, Hu J, Xu Z, Che L, Solomon D, Tsokos C, Shafizadeh N, Chen X, Gill R, Kakar S. Correlation of exon 3 ß-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma. Mod Pathol. 2016 Jul 29.
    View on PubMed
  12. Tsokos CG, Krings G, Yilmaz F, Ferrell LD, Gill RM. Proliferative index facilitates distinction between benign biliary lesions and intrahepatic cholangiocarcinoma. Hum Pathol. 2016 Nov; 57:61-67.
    View on PubMed
  13. Choi WT, Chang TT, Gill RM. Gastrointestinal Zygomycosis Masquerading as Acute Appendicitis. Case Rep Gastroenterol. 2016 Jan-Apr; 10(1):81-7.
    View on PubMed
  14. Gill RM, Buelow B, Mather C, Joseph NM, Alves V, Brunt EM, Liu TC, Makhlouf H, Marginean C, Nalbantoglu I, Sempoux C, Snover DC, Thung SN, Yeh MM, Ferrell LD. Hepatic small vessel neoplasm, a rare infiltrative vascular neoplasm of uncertain malignant potential. Hum Pathol. 2016 Apr 14.
    View on PubMed
  15. Klair JS, Yang JD, Abdelmalek MF, Guy CD, Gill RM, Yates K, Unalp-Arida A, Lavine JE, Clark JM, Diehl AM, Suzuki A. A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease. Hepatology. 2016 Jul; 64(1):85-91.
    View on PubMed
  16. Yeh MM, Belt P, Brunt EM, Kowdley KV, Wilson LA, Ferrell L. Acidophil bodies in nonalcoholic steatohepatitis. Hum Pathol. 2016 Jun; 52:28-37.
    View on PubMed
  17. Cho SJ, Ferrell LD, Gill RM. Expression of liver fatty acid binding protein in hepatocellular carcinoma. Hum Pathol. 2016 Apr; 50:135-9.
    View on PubMed
  18. Gill RM and Kakar S. S.E. Mills. Sternberg's Diagnostic Surgical Pathology. Chapter 36: Non-Neoplastic Liver Disease. 2015; 1663-1703.
    View on PubMed
  19. Ferrell LD, Gill RM, and Geisinger KR. Wick M, Livolsi V, Pfeifer J, Stelow E, Wakely P (eds). Silverberg's Principles and Practice of Surgical Pathology and Cytopathology. Neoplasms and Tumor-Like Conditions of the Liver. 2015; 2109-2144.
    View on PubMed
  20. Corey KE, Vuppalanchi R, Wilson LA, Cummings OW, Chalasani N. NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non-HDL-C levels. Aliment Pharmacol Ther. 2015 Feb; 41(3):301-9.
    View on PubMed

Go to UCSF Profiles, powered by CTSI